IL150128A0 - Substituted bisindolymaleimides for the inhibition of cell proliferation - Google Patents

Substituted bisindolymaleimides for the inhibition of cell proliferation

Info

Publication number
IL150128A0
IL150128A0 IL15012800A IL15012800A IL150128A0 IL 150128 A0 IL150128 A0 IL 150128A0 IL 15012800 A IL15012800 A IL 15012800A IL 15012800 A IL15012800 A IL 15012800A IL 150128 A0 IL150128 A0 IL 150128A0
Authority
IL
Israel
Prior art keywords
bisindolymaleimides
inhibition
substituted
cell proliferation
proliferation
Prior art date
Application number
IL15012800A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL150128A0 publication Critical patent/IL150128A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • C07F9/5728Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL15012800A 1999-12-16 2000-12-12 Substituted bisindolymaleimides for the inhibition of cell proliferation IL150128A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17105199P 1999-12-16 1999-12-16
PCT/EP2000/012559 WO2001044234A1 (en) 1999-12-16 2000-12-12 Substituted bisindolylmaleimides for the inhibition of cell proliferation

Publications (1)

Publication Number Publication Date
IL150128A0 true IL150128A0 (en) 2002-12-01

Family

ID=22622296

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15012800A IL150128A0 (en) 1999-12-16 2000-12-12 Substituted bisindolymaleimides for the inhibition of cell proliferation
IL150128A IL150128A (en) 1999-12-16 2002-06-10 Bisindolyls are converted to amylamides to prevent cell proliferation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL150128A IL150128A (en) 1999-12-16 2002-06-10 Bisindolyls are converted to amylamides to prevent cell proliferation

Country Status (33)

Country Link
US (1) US6313143B1 (cs)
EP (1) EP1242408B1 (cs)
JP (2) JP2003516986A (cs)
KR (1) KR100507422B1 (cs)
CN (1) CN1229374C (cs)
AR (1) AR029415A1 (cs)
AT (1) ATE306484T1 (cs)
AU (1) AU783616B2 (cs)
BR (1) BRPI0016329B8 (cs)
CA (1) CA2392902C (cs)
CO (1) CO5050293A1 (cs)
CZ (1) CZ304130B6 (cs)
DE (1) DE60023182T2 (cs)
ES (1) ES2249314T3 (cs)
GC (1) GC0000265A (cs)
HK (1) HK1054385B (cs)
HR (1) HRP20020513B1 (cs)
HU (1) HU230003B1 (cs)
IL (2) IL150128A0 (cs)
JO (1) JO2296B1 (cs)
MA (1) MA26856A1 (cs)
MX (1) MXPA02005560A (cs)
MY (1) MY126998A (cs)
NO (1) NO322240B1 (cs)
NZ (1) NZ519173A (cs)
PE (1) PE20011034A1 (cs)
PL (1) PL200243B1 (cs)
RS (1) RS50449B (cs)
RU (1) RU2264398C2 (cs)
TW (1) TWI274752B (cs)
UY (1) UY26485A1 (cs)
WO (1) WO2001044234A1 (cs)
ZA (1) ZA200204258B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102373A1 (en) * 2001-06-15 2002-12-27 F. Hoffmann-La Roche Ag Method for administration of cancer therapeutic
WO2003037384A2 (en) * 2001-10-29 2003-05-08 Nektar Therapeutics Al, Corporation Polymer conjugates of protein kinase c inhibitors
ES2768295T3 (es) 2010-01-07 2020-06-22 Alkermes Pharma Ireland Ltd Profármacos de compuestos heteroaromáticos
EP2474541A1 (en) * 2010-12-23 2012-07-11 Johannes- Gutenberg-Universität Mainz Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
MC2096A1 (fr) * 1989-02-23 1991-02-15 Hoffmann La Roche Pyrroles substitues
GB9416467D0 (en) * 1994-08-13 1994-10-05 Wellcome Found Compounds for use in medicine
NZ332234A (en) * 1996-03-12 2000-06-23 Pg Txl Company Lp Water soluble paclitaxel prodrugs formed by conjugating paclitaxel or docetaxel with a polyglutamic acid polymer and use for treating cancer
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
PE91698A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91498A1 (es) * 1996-07-29 1998-12-22 Hoffmann La Roche Pirroles sustituidos
PE91598A1 (es) 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
EP1045689A4 (en) * 1998-01-09 2003-04-23 Univ Arizona State SYNTHESIS OF PHENSTATIN AND ITS PRODUCTS
CZ299068B6 (cs) 1998-03-17 2008-04-16 F. Hoffmann-La Roche Ag Substituovaný bisindolylmaleinimid a farmaceutický prostredek s jeho obsahem
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
NZ518038A (en) * 1999-10-12 2004-02-27 F Substituted pyrroles as antiproliferative agents for the treatment of cancer

Also Published As

Publication number Publication date
DE60023182T2 (de) 2006-07-06
HK1054385B (zh) 2006-02-17
HUP0203696A3 (en) 2004-01-28
NO20022776L (no) 2002-06-11
CA2392902A1 (en) 2001-06-21
PE20011034A1 (es) 2001-10-12
ES2249314T3 (es) 2006-04-01
TWI274752B (en) 2007-03-01
HK1054385A1 (en) 2003-11-28
AU783616B2 (en) 2005-11-17
RU2002119209A (ru) 2004-01-10
EP1242408A1 (en) 2002-09-25
DE60023182D1 (de) 2006-02-23
JO2296B1 (en) 2005-09-12
MY126998A (en) 2006-11-30
WO2001044234A1 (en) 2001-06-21
HUP0203696A2 (hu) 2003-03-28
PL200243B1 (pl) 2008-12-31
KR100507422B1 (ko) 2005-08-10
KR20020063215A (ko) 2002-08-01
CA2392902C (en) 2009-01-13
RS50449B (sr) 2010-03-02
BR0016329B1 (pt) 2013-03-19
PL355856A1 (en) 2004-05-31
MXPA02005560A (es) 2002-09-02
CZ304130B6 (cs) 2013-11-13
UY26485A1 (es) 2001-06-29
MA26856A1 (fr) 2004-12-20
HRP20020513A2 (en) 2004-08-31
US6313143B1 (en) 2001-11-06
YU43302A (sh) 2005-03-15
JP4763623B2 (ja) 2011-08-31
NO20022776D0 (no) 2002-06-11
GC0000265A (en) 2006-11-01
CN1409709A (zh) 2003-04-09
CZ20022447A3 (cs) 2003-06-18
JP2003516986A (ja) 2003-05-20
BR0016329A (pt) 2002-08-27
NZ519173A (en) 2004-06-25
HRP20020513B1 (en) 2006-10-31
HU230003B1 (en) 2015-04-28
IL150128A (en) 2006-06-11
ATE306484T1 (de) 2005-10-15
BRPI0016329B8 (pt) 2021-05-25
NO322240B1 (no) 2006-09-04
AR029415A1 (es) 2003-06-25
RU2264398C2 (ru) 2005-11-20
CN1229374C (zh) 2005-11-30
ZA200204258B (en) 2003-08-28
CO5050293A1 (es) 2001-06-27
AU2008201A (en) 2001-06-25
JP2007153905A (ja) 2007-06-21
EP1242408B1 (en) 2005-10-12

Similar Documents

Publication Publication Date Title
AU8419201A (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
EP1237624A4 (en) DEVICE FOR INHIBITING CELL PROLIFERATION
IL148614A0 (en) Pteridinones as kinase inhibitors
GB9900416D0 (en) Inhibitors
IL144668A0 (en) The use of 4-h-1-benzopyran-4- one derivatives as inhibitors of smooth muscle cell proliferation
GB9929973D0 (en) Heterocyclic compounds
GB9922554D0 (en) Inhibition of secretion from non-neuronal cells
AU5170900A (en) Cell proliferation inhibitors
ZA972000B (en) Inhibition of proliferation of cells.
CY2483B1 (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation.
AU4296397A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
PL342964A1 (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
AP2002002413A0 (en) Heterocyclic compounds inhibiting angiogenesi
EP1153022A4 (en) PROTEASE INHIBITORS
EP1218407A4 (en) USES OF KAPPA-CONOTOXIN PVIIA
IL150128A0 (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
GB2389113B (en) B-secretase inhibitor
GB9907861D0 (en) The tracker
SI1064279T1 (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
SI1351958T1 (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
TW375277U (en) Structure of case for the electronic target
GB9904070D0 (en) Inhibition of scale
TW501766U (en) Floating structure of the adapted plate
GB9929341D0 (en) Inhibitors
GB9929340D0 (en) Inhibitors

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed